Cargando…
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer
BACKGROUND: CT scans are used in routine clinical practice for the diagnosis and treatment surveillance of non‐small cell lung cancer (NSCLC). However, more sensitive methods are desirable. Liquid biopsy analyses of RNA and DNA can offer more sensitive diagnostic approaches. Cell‐free RNA (cfRNA) ha...
Autores principales: | Metzenmacher, Martin, Hegedüs, Balazs, Forster, Jan, Schramm, Alexander, Horn, Peter A., Klein, Christoph A., Bielefeld, Nicola, Ploenes, Till, Aigner, Clemens, Siveke, Jens T., Schuler, Martin, Lueong, Smiths S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346179/ https://www.ncbi.nlm.nih.gov/pubmed/35708207 http://dx.doi.org/10.1111/1759-7714.14540 |
Ejemplares similares
-
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
por: Metzenmacher, Martin, et al.
Publicado: (2021) -
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer
por: Metzenmacher, Martin, et al.
Publicado: (2020) -
A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer
por: Seneviratne, Chamindi, et al.
Publicado: (2022) -
Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer
por: Safrastyan, Aram, et al.
Publicado: (2023) -
Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors
por: Raez, Luis E., et al.
Publicado: (2021)